SE7503689L - Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer - Google Patents

Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer

Info

Publication number
SE7503689L
SE7503689L SE7503689A SE7503689A SE7503689L SE 7503689 L SE7503689 L SE 7503689L SE 7503689 A SE7503689 A SE 7503689A SE 7503689 A SE7503689 A SE 7503689A SE 7503689 L SE7503689 L SE 7503689L
Authority
SE
Sweden
Prior art keywords
alkylamines
diaryl
oxadiazole
procedure
preparation
Prior art date
Application number
SE7503689A
Other languages
English (en)
Other versions
SE420492B (sv
Inventor
G W Adelstein
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE7503689L publication Critical patent/SE7503689L/sv
Publication of SE420492B publication Critical patent/SE420492B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7503689A 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer SE420492B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US456755A US3917615A (en) 1974-04-01 1974-04-01 1,1-Diaryl-1-oxadiazol-alkylamines

Publications (2)

Publication Number Publication Date
SE7503689L true SE7503689L (sv) 1975-10-02
SE420492B SE420492B (sv) 1981-10-12

Family

ID=23814026

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7503689A SE420492B (sv) 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE7503688A SE420491B (sv) 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7503688A SE420491B (sv) 1974-04-01 1975-04-01 Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer

Country Status (26)

Country Link
US (2) US3917615A (sv)
JP (2) JPS5939434B2 (sv)
AR (2) AR206425A1 (sv)
AT (2) AT342045B (sv)
BE (2) BE827323A (sv)
CA (2) CA1067498A (sv)
CH (2) CH614205A5 (sv)
CS (1) CS194718B2 (sv)
DE (2) DE2514229A1 (sv)
DK (2) DK137275A (sv)
EG (1) EG12104A (sv)
ES (2) ES436044A1 (sv)
FI (2) FI61895C (sv)
FR (2) FR2265376B1 (sv)
GB (2) GB1456943A (sv)
HU (1) HU170747B (sv)
IE (2) IE40894B1 (sv)
IL (2) IL46959A (sv)
NL (2) NL7503856A (sv)
NO (2) NO142173C (sv)
OA (1) OA04914A (sv)
PH (1) PH11423A (sv)
PL (1) PL99553B1 (sv)
SE (2) SE420492B (sv)
YU (1) YU39200B (sv)
ZA (2) ZA751193B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4003904A (en) * 1974-04-01 1977-01-18 G. D. Searle & Co. Anti-diarrheal oxadiazoles
US4025524A (en) * 1975-04-16 1977-05-24 G. D. Searle & Co. 2-{3-[4-Azatricyclo(4.3.1.13,8)undecan-4-yl]-1,1-diphenylpropyl}-5-methyl-1,3,4-oxadiazole and congeners
US4086227A (en) * 1975-04-16 1978-04-25 G. D. Searle & Co. Novel anti-diarrheal 4-azatricyclo[4.3.1.13,8 ] undecane derivatives
US4057549A (en) * 1975-04-16 1977-11-08 G. D. Searle & Co. Triarylpropyl-azabicyclooctanes
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
US3996214A (en) * 1976-02-23 1976-12-07 G. D. Searle & Co. 5-(1,1-Diphenyl-4-(cyclic amino) but-2-trans-en-1-yl)-2-alkyl-1,3,4-oxadiazoles and intermediates thereto
US4013668A (en) * 1976-03-10 1977-03-22 G. D. Searle & Co. 5-(1,1-diphenyl-3-(5- or 6-hydroxy-2-azabicyclo(2.2.2)oct-2-yl)propyl)-2-alkyl-1,3,4-oxadiazoles and related compounds
US4012393A (en) * 1976-03-22 1977-03-15 G. D. Searle & Co. 2-[5-(CYCLIC AMINO) ETHYL-10,11-DIHYDRO-5H-dibenzo[a,d]-cyclohepten-5- yl]-5
US4028364A (en) * 1976-07-06 1977-06-07 G. D. Searle & Co. 2-Azabicyclo[2.2.2.]octan-2-yl-diphenyl-alkanones and related compounds
US4053477A (en) * 1976-09-20 1977-10-11 G. D. Searle & Co. 5-(1,1-diphenyl-3-(4-phenylpiperidino)propyl)-2-methyl-1,3,4-oxadiazole and related compounds
US4194045A (en) * 1977-12-27 1980-03-18 G. D. Searle & Co. 1-(3,3-Diaryl-3-oxadiazolalkyl)-4-phenyl-4-piperidinomethanols and related compounds
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds
US4596801A (en) 1983-03-24 1986-06-24 Chugai Seiyaku Kabushiki Kaisha 4H-3,1-benzoxazine derivatives, process for producing the same and agricultural or horticultural fungicide containing the same
JPS61194917A (ja) * 1985-02-23 1986-08-29 Matsushita Electric Works Ltd 遅れスイツチ
JPS61195022A (ja) * 1985-02-25 1986-08-29 Matsushita Electric Works Ltd 遅れスイツチ
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
DK40890D0 (da) * 1990-02-16 1990-02-16 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
PT2012164573W (pt) 2011-05-27 2014-10-08 Reliance Ind Ltd Procedimento para a preparação de um ácido carboxílico orgânico por hidrólise de um ester de ácido carboxílico orgânico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141019A (en) * 1964-07-14 Chaohj
US3299044A (en) * 1964-05-13 1967-01-17 Searle & Co Complex n-substituted azabicycloalkanes
FR1469022A (fr) * 1965-12-14 1967-02-10 Chimie Et Synthese De Picardie Nouveaux dérivés oxadiazoliques et leur procédé de préparation
GB1174411A (en) * 1966-03-02 1969-12-17 Aspro Nicholas Ltd Novel Benzothiophen Compounds, Compositions containing them and processes for their manufacture
GB1231829A (sv) * 1968-09-19 1971-05-12
US3720685A (en) * 1970-07-15 1973-03-13 Squibb & Sons Inc 3-amino-5-benzyl-1,2,4-oxadiazoles

Also Published As

Publication number Publication date
IL46959A (en) 1978-03-10
PL99553B1 (pl) 1978-07-31
HU170747B (sv) 1977-08-28
ZA751193B (en) 1976-04-28
GB1456943A (en) 1976-12-01
AR206341A1 (es) 1976-07-15
BE827324A (fr) 1975-09-29
GB1494943A (en) 1977-12-14
CS194718B2 (en) 1979-12-31
CH613964A5 (sv) 1979-10-31
NO142173B (no) 1980-03-31
JPS50135081A (sv) 1975-10-25
IE40895L (en) 1975-10-01
CH614205A5 (sv) 1979-11-15
SE420491B (sv) 1981-10-12
JPS5939434B2 (ja) 1984-09-22
JPS50135086A (sv) 1975-10-25
ES436044A1 (es) 1977-05-01
FR2265376B1 (sv) 1980-02-22
AR206425A1 (es) 1976-07-23
NL7503849A (nl) 1975-10-03
JPS5936631B2 (ja) 1984-09-05
US3917615A (en) 1975-11-04
DK137375A (sv) 1975-10-02
ATA245275A (de) 1977-07-15
PH11423A (en) 1978-01-09
AU7958575A (en) 1976-09-30
IL46966A0 (en) 1975-05-22
IE40895B1 (en) 1979-09-12
NO142174C (no) 1980-07-09
FR2265376A1 (sv) 1975-10-24
ES436160A1 (es) 1977-02-01
ATA245175A (de) 1977-05-15
NO142173C (no) 1980-07-09
FI61895B (fi) 1982-06-30
AT340916B (de) 1978-01-10
NO751103L (sv) 1975-10-02
EG12104A (en) 1978-06-30
CA1053672A (en) 1979-05-01
DE2514229A1 (de) 1975-10-09
IE40894L (en) 1975-10-01
DK137275A (sv) 1975-10-02
FI63572B (fi) 1983-03-31
FR2265367A1 (sv) 1975-10-24
NL7503856A (nl) 1975-10-03
OA04914A (fr) 1975-10-31
SE7503688L (sv) 1975-10-02
FI750966A (sv) 1975-10-02
YU81675A (en) 1982-02-28
FR2265367B1 (sv) 1978-07-28
FI61895C (fi) 1982-10-11
NO751104L (sv) 1975-10-02
SE420492B (sv) 1981-10-12
IL46966A (en) 1977-11-30
IL46959A0 (en) 1975-05-22
ZA751986B (en) 1976-06-30
DE2514183A1 (de) 1975-10-09
NO142174B (no) 1980-03-31
FI750965A (sv) 1975-10-02
BE827323A (fr) 1975-09-29
AU7958475A (en) 1976-09-30
USRE29556E (en) 1978-02-28
YU39200B (en) 1984-08-31
CA1067498A (en) 1979-12-04
AT342045B (de) 1978-03-10
IE40894B1 (en) 1979-09-12
FI63572C (fi) 1983-07-11

Similar Documents

Publication Publication Date Title
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
SE7503689L (sv) Forfarande for framstellning av 1,1-diaryl-1-oxadiazol-alkylaminer
SE7710600L (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE7513085L (sv) Forfarande for framstellning av etrar
SE7810002L (sv) Forfarande for framstellning av fenylalkylaminer
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE428015B (sv) Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat
SE431451B (sv) Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7512422L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE426067B (sv) Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
NO139684C (no) Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid
SE7507482L (sv) Forfarande for framstellning av substituerade l-sulfonylbensimidazoler.
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
NO149427C (no) Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner.
SE422206B (sv) Forfarande for framstellning av 2-halogenmetyl-1,4-bensodiazepiner
SE408898B (sv) Foerfarande foer framstaelling av en 17-monoester av 17alfa, 21-dihydroxisteroider
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE7505066L (sv) Forfarande for framstellning av cefalsporinderivat.